Myrava
Myrava is a US medical technology company providing point-of-care, patient-specific FDA-cleared medical devices (anatomic models, radiation therapy devices) using additive manufacturing, formerly operating as Ricoh 3D for Healthcare.
- CEO / Founder
- Gary Turner
- Team Size
- 11-50
- Stage
- Active
Technology & Products
Key Products
Anatomic Models (patient-specific devices from MRI/CT data for pre-surgical planning and education); Radiation Therapy devices (custom devices for precision radiation treatment); Co-located Services (on-site production teams within healthcare facilities).
Technological Advantage
ISO 13485:2016 certified quality systems, FDA clearances, and an experienced leadership team with 5+ years of prior operating history as Ricoh 3D for Healthcare.
Differentiation
Value Proposition
Point-of-care manufacturing of FDA-cleared, patient-specific medical devices co-located within healthcare facilities for faster turnaround.
How They Differentiate
Co-located, point-of-care production model embedded within hospital systems rather than centralized/offsite manufacturing, backed by an established FDA-cleared regulatory track record from its Ricoh 3D for Healthcare heritage.
Market & Competition
Target Customers
Hospitals and healthcare systems, radiation oncology and surgical planning departments.
Industry Verticals
Medical & Healthcare (surgical planning, radiation oncology, orthopedics)
Competitors
Insight Surgery (formerly 3D LifePrints); Axial3D; Materialise (medical device/anatomic modeling divisions)
Growth & Milestones
Growth Metrics
Expanded R&D lab space in Winston-Salem, NC (Nov 2025, +450 sq ft, 6 new jobs); awarded first BioNest Fund grant (up to $25,000).
Major Milestones
2025: Operated as Ricoh 3D for Healthcare, LLC under Ricoh USA, launched patient-specific device business, opened Innovation Studio in North Carolina; Nov 2025: Awarded BioNest Fund grant, expanded R&D lab; Jul 2026: Ricoh USA divested the business, rebranded as independent company Myrava, Inc.